Skip to Main Content

Paper Details

Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma.
J Pathol
2
2023
CD274, CD279, CD3, CD4, CD68, CD8, FoxP3, HLA-DR, LAG-3, LAG-3 lymphocyte populations, MHC-II, PD-1, PD-L1, SOX10, TCF1/7, UC, circulating immune populations, intratumoral CD3 LAG-3 cells, pancytokeratin, patients, tissue, urothelial carcinoma
Author NameAffiliation
Katherine S PanageasMemorial Sloan Kettering Cancer Center
Ronglai ShenMemorial Sloan Kettering Cancer Center
Travis J HollmannMemorial Sloan Kettering Cancer Center
Travis J HollmannParker Institute for Cancer Immunotherapy
Travis J Hollmann
  • 1 - 5

Datasets

Release 1.2